All In Biotech

Free tool

FAERS Monitor: Renova

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021108 or its brand name (Renova, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

6,666

Serious

4,154

62% of reports

Hospitalization

1,431

Death reported

856

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use885
  • drug ineffective747
  • pain499
  • product use in unapproved indication483
  • vomiting452
  • paraesthesia376
  • abdominal pain upper368
  • rash367
  • nausea353
  • diarrhoea350
  • headache339
  • maternal exposure during pregnancy339
  • taste disorder332
  • gastrooesophageal reflux disease329
  • drug intolerance327

Reports by year received

View as table
YearReports
200438
200533
200628
200740
2008115
200976
201080
201195
2012160
2013106
2014150
2015246
2016364
2017358
2018473
2019364
2020383
2021430
2022510
2023569
2024676
2025810
2026562

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,493 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
taste disorderSignal33252.547.216,456
gastrooesophageal reflux diseaseSignal32912.911.63,613
maternal exposure during pregnancySignal33912.010.93,423
drug intoleranceSignal32710.79.62,874
paraesthesiaSignal3767.66.82,143
product use in unapproved indicationSignal4836.25.72,103
abdominal pain upperSignal3685.65.11,414
off label useSignal8853.23.01,386
vomitingSignal4523.02.8628
rashSignal3672.72.4386
painSignal4992.62.4489
drug ineffective7471.81.7276
diarrhoea3501.71.5106
headache3391.71.5101
nausea3531.41.343

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.